share_log

Maxim Group Upgrades Palisade Bio to Buy, Announces $50 Price Target

Benzinga ·  Mar 30, 2023 09:22

Maxim Group analyst Naz Rahman upgrades Palisade Bio (NASDAQ:PALI) from Hold to Buy and announces $50 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment